Reviewer
Jijun Cheng
  • VP, R&D, Shanghai LIDE Biotech
Research focus
  • Cancer biology
  • drug discovery, patient-derived xenograft, genome editing
  • 1 Author merit
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.